This study confirms that BRCA1 or BRCA2 mutations are associated with improved long-term survival in ovarian cancer patients of Ashkenazi origin, the researchers conclude.

• 研究者的结论是，这项研究确认了BRCA1与BRCA2基因突变，与中欧犹太人裔卵巢癌患者的长期存活率较佳有关；